null

SARS-CoV Spike RBD Monoclonal Antibody (CAB21181)

SKU:
CAB21181
Product Type:
Antibody
Antibody Type:
Monoclonal Antibody
Reactivity:
SARS-CoV-2
Host Species:
Rabbit
Isotype:
IgG
Applications:
WB
€139 - €529
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

SARS-CoV Spike RBD Monoclonal Antibody (CAB21181)

The SARS-CoV Spike RBD Monoclonal Antibody (CAB21181) is a specialized antibody designed for research involving the Spike Receptor Binding Domain (RBD) of the SARS-CoV virus. This monoclonal antibody, produced through advanced technology, is highly specific and sensitive for detecting the SARS-CoV Spike RBD protein in various biological samples.The SARS-CoV Spike RBD is a critical component of the virus responsible for binding to host cell receptors, facilitating viral entry, and initiating infection. By targeting the Spike RBD, researchers can better understand the mechanisms of SARS-CoV infection and develop strategies for diagnostic testing and vaccine development.

This monoclonal antibody is validated for use in a range of applications, including Western blotting, immunofluorescence, and immunohistochemistry, making it a valuable tool for studying the SARS-CoV virus and its interactions with host cells. Its high specificity and sensitivity ensure reliable and accurate results, making it ideal for research projects focused on developing antiviral therapies and understanding the immune response to SARS-CoV infection.